What they do: BenevolentAI was founded in 2013 by Ken Mulvany following the sale of Proximagen, a successful biotech business that Ken founded.  The experience of running a biotech, a company in an industry entirely reliant on scientific breakthroughs, highlighted the challenges of innovating using a process of scientific discovery that had not largely changed for 50 years. 


Location: London, England

Type: Healthcare Tech

NewsEurope is home to 14 tech unicorns. This is where they live